448
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Update on systemic therapy of advanced non-small-cell lung cancer

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lu Li, Mei Feng, Peng Xu, Yi Lin Wu, Jun Yin, Yecai Huang, Ming Yu Tan & Lang Jinyi. (2023) Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC. International Journal of Neuroscience 133:3, pages 334-341.
Read now

Articles from other publishers (19)

Linlin Wu, Wenxue Sun, Dehua Liao, Yujin Guo, Qingying Si, Dadi Xie & Pei Jiang. (2023) Overexpression of DAPK1 and Beclin1 under oxygen and glucose deprivation conditions promotes excessive autophagy and apoptosis in A549 cells. MedComm – Oncology 2:2.
Crossref
Lingling Wang, Xing Zhao, Huachuan Zheng, Cuimin Zhu & Yanhong Liu. (2022) AIF-1, a potential biomarker of aggressive tumor behavior in patients with non-small cell lung cancer. PLOS ONE 17:12, pages e0279211.
Crossref
Vidya Devanathadesikan Seshadri, Atif Abdulwahab A. Oyouni, Yousef M. Hawsawi, Saad Ali S. Aljohani, Osama M. Al-Amer, Waseem AlZamzami & Ahmad Hasan Mufti. (2022) Chemopreventive role of Tin oxide-Chitosan-Polyethylene glycol-Crocin nanocomposites against Lung cancer: An in vitro and in vivo approach. Process Biochemistry 120, pages 186-194.
Crossref
Weizheng Fu, Qingsheng Kan, Bin Li & Xiaoming Zhang. (2022) Prognosis Model of Advanced Non-Small-Cell Lung Cancer Based on Max-Min Hill-Climbing Algorithm. Computational and Mathematical Methods in Medicine 2022, pages 1-10.
Crossref
Marija Ivanović, Lea Knez, Ana Herzog, Mile Kovačević & Tanja Cufer. (2021) Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center. The Oncologist 26:12, pages e2143-e2150.
Crossref
Jingyao Li, Yang Qiu, Junxiu Yi, Xi Liu, Shixin Zhang, Deli Tan, Tao Jing, Yi Liao, Meng Tang, Jie Liu & Haidong Wang. (2021) Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers RRM1, TUBB3, and ERCC1. Journal of Oncology 2021, pages 1-8.
Crossref
Ana Koren, Matija Rijavec, Tomaž Krumpestar, Izidor Kern, Aleksander Sadikov, Tanja Čufer & Peter Korošec. (2021) Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins PHD1 and PHD2 but Not PHD3 Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer. Cancers 13:10, pages 2309.
Crossref
Al Hassan Kyakulaga, Farrukh Aqil, Radha Munagala & Ramesh C. Gupta. (2020) Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells. Oncotarget 11:16, pages 1399-1416.
Crossref
Fang Yuan, Suyun Zhang, Wenying Xie, Sheng Yang, Tingyan Lin & Xiangqi Chen. (2020) Effect and mechanism of miR‑146a on malignant biological behaviors of lung adenocarcinoma cell line. Oncology Letters.
Crossref
Jia Hou, Shan-Shan Xiong, Zhao-Qi Huang & Xing-Dong Cai. (2019) Decelerated tumor growth due to hypothyroidism with prolongation of survival in a patient with lung adenocarcinoma: a case report. Journal of International Medical Research 48:3, pages 030006051988530.
Crossref
Hao Wang, Chenxin Zeng, Xin Li, Youjie Wang, Xinyi Li & Weihong Ge. (2019) Cost-utility of afatinib and gefitinib as first-line treatment for EGFR -mutated advanced non-small-cell lung cancer . Future Oncology 15:2, pages 181-191.
Crossref
Raimondo Di Liello, Vincenza Ciaramella, Giusi Barra, Massimo Venditti, Carminia Maria Della Corte, Federica Papaccio, Francesca Sparano, Giuseppe Viscardi, Maria Lucia Iacovino, Sergio Minucci, Morena Fasano, Fortunato Ciardiello & Floriana Morgillo. (2019) Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study. ESMO Open 4:4, pages e000536.
Crossref
Marisa A. Bittoni, Ashwini Arunachalam, Haojie Li, Ramon Camacho, Jinghua He, Yichen Zhong, Gregory M. Lubiniecki & David P. Carbone. (2018) Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study. Clinical Lung Cancer 19:5, pages e629-e645.
Crossref
Ana Koren, Matija Rijavec, Eva Sodja, Izidor Kern, Aleksander Sadikov, Viljem Kovac, Peter Korosec & Tanja Cufer. (2017) High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients . Oncotarget 8:15, pages 25384-25394.
Crossref
Hongchang Shen, Liguang Wang, Jiangang Zhang, Wei Dong, Tiehong Zhang, Yang Ni, Hongxin Cao, Kai Wang, Yun Li, Yibing Wang & Jiajun Du. (2016) ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response. Oncology Reports.
Crossref
Giuseppe Roscilli, Claudia De Vitis, Fabiana Fosca Ferrara, Alessia Noto, Emanuela Cherubini, Alberto Ricci, Salvatore Mariotta, Enrico Giarnieri, Maria Rosaria Giovagnoli, Maria Rosaria Torrisi, Francesca Bergantino, Susan Costantini, Francesca Fenizia, Matilde Lambiase, Luigi Aurisicchio, Nicola Normanno, Gennaro Ciliberto & Rita Mancini. (2016) Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity. Journal of Translational Medicine 14:1.
Crossref
Yen-Jen Chen, Hsien-Te Chen & Horng-Chaung Hsu. (2015) Preoperative palsy score has no significant association with survival in non-small-cell lung cancer patients with spinal metastases who undergo spinal surgery. Journal of Orthopaedic Surgery and Research 10:1.
Crossref
Ana Koren, Eva Sodja, Matija Rijavec, Mojca Jez, Viljem Kovac, Peter Korosec & Tanja Cufer. (2015) Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients. Cellular Oncology 38:5, pages 387-395.
Crossref
Bogdana Suchorska, Joerg C. Tonn & Nathalie L. Jansen. (2014) PET imaging for brain tumor diagnostics. Current Opinion in Neurology 27:6, pages 683-688.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.